SLIC1 Inhibitors
Chemical inhibitors of the protein SLIC1 include a variety of compounds that target different kinases and signaling pathways with which the protein is involved. Genistein can serve as an inhibitor of tyrosine kinases, which are integral to the phosphorylation processes within cells. The inhibition of these kinases by genistein can lead to a reduction in phosphorylation events that are necessary for the proper functioning of SLIC1. Similarly, staurosporine, a non-selective inhibitor of protein kinases, can disrupt a broad range of phosphorylation-dependent signaling pathways, thereby potentially impairing SLIC1 activity. Staurosporine's broad-spectrum inhibition may affect the activity of SLIC1 by preventing essential phosphorylation on either the protein itself or its interacting partners.
Compounds like wortmannin and LY294002, which are specific phosphoinositide 3-kinases (PI3K) inhibitors, can suppress the PI3K/Akt pathway. If SLIC1 is associated with this pathway, the inhibition by these chemicals can reduce its activity. In a similar vein, PD98059, an inhibitor of MEK, and U0126, which targets MEK1/2, can decrease the activity of SLIC1 if it is involved in the MAPK/ERK pathway. SP600125 and SB203580, which are inhibitors of c-Jun N-terminal kinase (JNK) and p38 MAP kinase respectively, can decrease SLIC1 activity if it is connected to the JNK or p38 MAPK signaling pathways. Lastly, Go6983, GF109203X, Chelerythrine chloride, and LY333531 which inhibit protein kinase C (PKC) and its specific isozymes, can lead to reduced SLIC1 activity by impeding PKC-mediated regulatory mechanisms. The inhibition of PKC, whether broad-spectrum or isozyme-specific, can alter the functional state of SLIC1, depending on its reliance on PKC for proper activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an isoflavone that inhibits tyrosine kinases. Since SLIC1 is a membrane protein potentially involved in signal transduction, the inhibition of tyrosine kinases can lead to a decrease in phosphorylation events that SLIC1 might be involved in, thereby inhibiting its function. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent non-selective inhibitor of protein kinases. By broadly inhibiting kinases, staurosporine can impair the phosphorylation of proteins including SLIC1 or its interacting partners, which is essential for SLIC1's activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a specific inhibitor of phosphoinositide 3-kinases (PI3K). If SLIC1's function is connected to the PI3K/Akt pathway, inhibition of this pathway by wortmannin could result in a decrease in SLIC1's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor. Similar to wortmannin, if SLIC1 is involved in the PI3K/Akt signaling pathway, LY294002 can inhibit this pathway and consequently inhibit the activity of SLIC1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK). If SLIC1 is involved in the MAPK/ERK pathway, inhibition of MEK by PD98059 can result in reduced activity of SLIC1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If SLIC1 is functionally connected to the JNK signaling pathway, inhibiting JNK with SP600125 could lead to a decrease in SLIC1 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. If SLIC1 operates within the p38 MAPK pathway, inhibiting this kinase with SB203580 would result in decreased SLIC1 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2. If SLIC1 is part of the ERK/MAPK pathway, U0126 can inhibit this pathway and thus inhibit the activity of SLIC1. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a broad-spectrum protein kinase C inhibitor. If SLIC1 is regulated by PKC-mediated phosphorylation, using Go6983 to inhibit PKC could reduce SLIC1 activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X, also known as bisindolylmaleimide I, is another PKC inhibitor. If PKC influences SLIC1's activity, inhibition of PKC by GF109203X could lead to a functional inhibition of SLIC1. | ||||||